3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Multiple Myeloma
52
Neoplasms, Plasma Cell
5
Neoplasms
4
Lymphoma
4
Waldenstrom Macroglobulinemia
3
Recurrence
3
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Breast Neoplasms
2
Bone Neoplasms
2
Back Pain
2
Venous Thromboembolism
1
Stomatitis
1
Skin Neoplasms
1
Renal Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia, Pneumococcal
1
Pneumococcal Infections
1
Peripheral Nervous System Diseases
1
Pain
1
Osteoporosis
1
Osteonecrosis
1
Osteolysis
1
Myeloproliferative Disorders
1
Multiple Sclerosis
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Acquired Immunodeficiency Syndrome
×
Plasma cell
×
Clear all
NCT04952766
2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4
Completed
196 enrolled